Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2010, Vol. 4 Issue (1) : 96-100     DOI: 10.1007/s11684-010-0001-1
Research articles |
Technetium-99m-sestamibi SPECT for the diagnosis and follow-up of nasopharyngeal carcinoma
Jing CHEN MD1,Guang-Yuan HU MD2,Guo-Qing HU MD2,Hua WU PhD3,
1.Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 2.Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 3.Department of Nuclear Medicine, Xiamen First Hospital, Fujian Medical University, Xiamen 361003, China;
Download: PDF(137 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  This study was to investigate a better way to detect and differentiate primary, residual, recurrent nasopharyngeal carcinoma (NPC) lesions post-radiotherapy in patients with NPC by means of routine computed tomography (CT) in combination with 99Tcm-sestamibi single photon emission computed tomography (99Tcm-MIBI SPECT). Forty-eight patients with histologically confirmed primary NPC underwent 99Tcm-MIBI SPECT at the 3rd month before and after radiotherapy, and at the 6th month after radiotherapy. All patients had contemporaneous CT examinations. Histopathologic results and/or clinical follow-up data (over 18 months) were used as the golden standard for evaluating residual/recurrent lesions. The radioactive count ratio of nasopharynx to scalp was obtained as the MIBI uptake index (MUI). Receiver operating characteristic analysis was employed to define the cut-off value of MUI for malignancy. With MUI 2.15 as the cut-off point, the accuracy for detecting primary NPC was 94.12%. The mean MUI in the local-regional of the nasopharynx in such negative cases was 1.21±€0.12 at the 3rd month, while the mean MUI was higher in the other 15 patients with histologically confirmed recurrent/residual lesions (MUI=1.40€±€0.16, t=4.71, P<0.001). The optimal cut-off point of 1.33 of MUI was defined with 89.58% accuracy for differentiating residual/recurrent lesions from the benign process post radiotherapy, while CT evaluations showed an accuracy of 81.25%. A combination of CT and 99Tcm-MIBI SPECT for 37 NPC patients with congruent results showed an accuracy of 97.30% for differentiating residual/recurrent NPC from benign lesions. 99Tcm-MIBI SPECT plays a role in evaluating residual/recurrent lesions post-radiotherapy. The combination of CT and 99Tcm-MIBI SPECT can give more accurate diagnosis in the follow-up of NPC.
Keywords nasopharyngeal carcinoma      diagnosis      follow-up      
Issue Date: 05 March 2010
URL:     OR
Chang E T, Adami H O. The enigmaticepidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomakers Prev, 2006, 15(10): 1765―1777

doi: 10.1158/1055-9965.EPI-06-0353
Yu M C, Yuan J M. Epidemiologyof nasopharyngeal carcinoma. Semin CancerBiol, 2002, 12(6): 421―429

doi: 10.1016/S1044579X02000858
Abdulamir A S, Hafidh R R, Adbulmuhaimen N, Abubakar F, Abbas K A. The distinctiveprofile of risk factors of nasopharyngeal carcinoma in comparisonwith other head and neck cancer types. BMC Public Health, 2008, 5(8): 400

doi: 10.1186/1471-2458-8-400
Mcdermott A L, Dutt S N, Watkinson J C. The aetiology of nasopharyngealcarcinoma. Clin Otolarynqol Allied Sci, 2001, 26(2): 82―89

doi: 10.1046/j.1365-2273.2001.00449.x
Jeyakumar A, Brickman T M, Jeyakumar A, Doerr T. Review of nasopharyngeal carcinoma. Ear Nose Throat J, 2006, 85(3): 168―173
Guiqay J. Advances in nasopharyngeal carcinoma. Curr Opin Oncol, 2008, 20(3): 264―269

doi: 10.1097/CCO.0b013e3282fad846
Faivre S, Janot F, Armand J P. Optimal management of nasopharyngealcarcinoma. Curr Opin Oncol, 2004, 16(3): 231―235

doi: 10.1097/00001622-200405000-00007
Liu T, Xu W, Yan W L, Ye M, Bai Y R, Huang G. FDG-PET, CT, MRI for diagnosis of local residual or recurrentnasopharyngeal carcinoma, which one is the best? A systematic review. Radiother Oncol2007, 85(3): 327―335

doi: 10.1016/j.radonc.2007.11.002
Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M. Detection and restaging ofresidual and/or recurrent nasopharyngeal carcinoma after chemotherapyand radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology, 2008, 249(1): 203―211

doi: 10.1148/radiol.2491071753
Liu S H, Chang J T, Nq S H, Chan S C, Yen T C. False positive fluorine-18fluorodeoxy-D-glucose positron emission tomography finding causedby osteoradionecrosis in a nasopharyngeal carcinoma patient. Br J Radiol, 2004, 77(915): 257―260

doi: 10.1259/bjr/69516821
Kao C H, Shiau Y C, Shen Y Y, Yen R F. Detection of recurrent or persistent nasopharyngeal carcinomas afterradiotherapy with technetium-99m methoxyisobutylisonitrile singlephoton emission computed tomography and computed tomography: comparisonwith 18-fluoro-2-deoxyglucose positron emission tomography. Cancer, 2002, 94(7): 1981―1986

doi: 10.1002/cncr.10400
Kao C H, Tsai S C, Wang J J, Ho Y J, Yen R F, Ho S T. Comparing 18-fluoro-2-deoxyglucose positron emissiontomography with a combination of technetium 99m tetrofosmin singlephoton emission computed tomography and computed tomography to detectrecurrent or persistent nasopharyngeal carcinomas after radiotherapy. Cancer, 2001, 92(2): 434―439

doi: 10.1002/1097-0142(20010715)92:2<434::AID-CNCR1339>3.0.CO;2-O
Chan S C, Ng S H, Chang J T C, Lin C Y, Chang Y C, Hsu C L, Wang H M, Liao C T, Yen T C. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucosepositron emission tomography in detecting locally residual or recurrentnasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging, 2006, 33(9): 1032―1040

doi: 10.1007/s00259-005-0054-6
Yen T C, Chang Y C, Chan S C, Chang J T, Hsu C H, Lin K J, Lin W J, Fu Y K, Nq S H. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinomato assess the primary tumour and loco-regional nodes? Eur J Nucl Med Mol Imaging, 2005, 32(5): 541―548

doi: 10.1007/s00259-004-1719-2
Nq S H, Joseph C T, Chan S C, Ko S F, Wang H M, Liao C T, Chang Y C, Lin W J, Fu Y K, Yen T C. Clinical usefulness of 18F-FDGPET in nasopharyngeal carcinoma patients with questionable MRI findingsfor recurrence. J Nucl Med, 2004, 45(10): 1669―1676
Yen T C, Chang J T, Nq S H, Chang Y C, Chan S C, Lin K J, Lin W J, Fu Y K, Lin C Y. The value of 18F-FDG PET in the detection of stage M0 carcinoma ofthe nasopharynx. J Nucl Med, 2005, 46(3): 405―410
Yen R F, Hong R L, Tzen K Y, Pan M H, Chen T H. Whole-body 18F-FDG PET inrecurrent or metastatic nasopharyngeal carcinoma. J Nucl Med, 2005, 46(5): 770―774
Chen J, Wu H, Zhou J, Hu G Q. Using Tc-99m MIBI scintimammography to differentiate nodular lesionsin breast and detect axillary lymph node metastases from breast cancer. Chin Med J (Engl), 2003, 116(4): 620―640
Sato T, Kawabata Y, Iwashita Y, Suenaga S, Indo H, Hamahira S, Kawano K, Nitta T, Morita Y, Majima H, Sugihara K. Interpretation of scintigraphic findingsof oral malignant tumours with a new scanning agent of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile(Tc-99m-MIBI). Dentomaxillofac Radiol, 2006, 35(1): 24―29

doi: 10.1259/dmfr/96590988
Sato T, Kawabata Y, Kobayashi Y, Suenaqa S, Indo H, Kawano K, Iwashita Y, Morita Y, Majima H J. Scintigraphy for interpretation of malignant tumoursof the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile(Tc-MIBI) and thallium-201-chloride (Tl-201). Dentomaxillofac Radiol, 2005, 34(5): 268―273

doi: 10.1259/dmfr/65143191
Baldari S, Resifo Pecorella G, Cosentino S, Minutoli F. Investigation of brain tumours with (99m)Tc-MIBI SPET. Q J Nucl Med, 2002, 46(4): 336―345
Yamamoto Y, Nishiyama Y, Toyama Y, Kunishio K, Satoh K, Ohkawa M. 99mTc-MIBI and 201Tl SPET in the detectionof recurrent brain tumours after radiation therapy. Nucl Med Commun, 2002, 23(12): 1183―1190

doi: 10.1097/00006231-200212000-00006
Villa G, Balleari E, Carletto M, Grosso M, Clavio M, Piccardo A, Rebella L, Tommasi L, Morbelli S, Peschiera F, Gobbi M, Ghio R. Staging and therapy monitoring of multiple myeloma by99mTc-sestamibi scintigraphy: a five year single center experience. J Exp Clin Cancer Res, 2005, 24(3): 355―361
Svaldi M, Tappa C, Gebert U, Bettini D, Fabri P, Franzelin F, Osele L, Mitterer M. Technetium-99m-sestamibi scintigraphy:an alternative approach for diagnosis and follow-up of active myelomalesions after high-dose chemotherapy and autologous stem cell transplantation. Ann Hematol, 2001, 80(7): 393―397

doi: 10.1007/s002770100318
Myslivecek M, Nekula J, Bacovsky J, Scudla V, Koranda P, Kaminek M. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphyand MRI in its diagnosis and therapy. NuclMed Rev Cent East Eur, 2008, 11(1): 12―16
Berberoglu K, Unal S N, Kebudi R, Turkmen C, Cantez S. Role of 99mTc-hexakis-2-methoxyisobutylisonitrilefor detecting marrow metastases in childhood solid tumours. Nucl Med Commun, 2005, 26(12): 1075―1080

doi: 10.1097/00006231-200512000-00005
Moustafa H, Riad R, Omar W, Zaher A, Ebied E. 99mTc-MIBI in the assessmentof response to chemotherapy and detection of recurrences in bone andsoft tissue tumours of the extremities. Q J Nucl Med, 2003, 47(1): 51―57
Pace L, Catalano L, Del Vecchio S, Di Gennaro F, De Renzo A, Sica G, Califano C, Tedesco N, Borrelli G, Rotoli B, Salvatore M. Predictive value of technetium-99m sestamibi in patients with multiplemyeloma and potential role in the follow-up. Eur J Nucl Med, 2001, 28(3): 304―312

doi: 10.1007/s002590000440
Yin H X, Ye W L. NasopharyngealCarcinoma. Beijing: China Union Medical University Press, 2002, 111
Du J Q, Yue D C, Pui M H, Zeng S Q, Ren Z G, Liu S H, Liu Z J. 99mTc-MIBIimaging in the follow-up of nasopharyngeal carcinomas. Zhong Hua He Yi Xue Za Zhi, 1998, 18(4): 238 (in Chinese)
[1] Jing Zhang,Shan Gao,Zhongping Duan,Ke-Qin Hu. Overview on acute-on-chronic liver failure[J]. Front. Med., 2016, 10(1): 1-17.
[2] Lijuan Hu,Zhirui Lin,Yanheng Wu,Juqin Dong,Bo Zhao,Yanbing Cheng,Peiyu Huang,Lihua Xu,Tianliang Xia,Dan Xiong,Hongbo Wang,Manzhi Li,Ling Guo,Elliott Kieff,Yixin Zeng,Qian Zhong,Musheng Zeng. Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing[J]. Front. Med., 2016, 10(1): 61-75.
[3] Wanqiu Huang,Yang Luan,Lu Jin,Tao Wang,Ruibao Chen,Zheng Liu,Zhiqiang Chen,Ruzhu Lan. Small cell carcinoma of the urinary bladder without gross hematuria: a case report[J]. Front. Med., 2015, 9(3): 384-387.
[4] Yi Cao. Environmental pollution and DNA methylation: carcinogenesis, clinical significance, and practical applications[J]. Front. Med., 2015, 9(3): 261-274.
[5] Lingqiang Zhang,Runchen Miao,Xiude Zhang,Wei Chen,Yanyan Zhou,Ruitao Wang,Ruiyao Zhang,Qing Pang,Xinsen Xu,Chang Liu. Exploring the diagnosis markers for gallbladder cancer based on clinical data[J]. Front. Med., 2015, 9(3): 350-355.
[6] Farhad Sahebjam,John M. Vierling. Autoimmune hepatitis[J]. Front. Med., 2015, 9(2): 187-219.
[7] Somanath Padhi, Renu G’ Boy Varghese, Anita Ramdas, Manjiri Dilip Phansalkar, RajLaxmi Sarangi. Hemophagocytic lymphohistiocytosis: critical reappraisal of a potentially under-recognized condition[J]. Front Med, 2013, 7(4): 492-498.
[8] Salomone Di Saverio, Kenji Kawamukai, Andrea Biscardi, Silvia Villani, Luca Zucchini, Gregorio Tugnoli. Trauma-induced “Macklin effect” with pneumothorax and large pneumomediastinum, disguised by allergy[J]. Front Med, 2013, 7(3): 386-388.
[9] Xianghu Meng, Jihong Liu, Xiao Yu, Shaogang Wang, Cong Liu, Zhangqun Ye. A giant Müllerian duct cyst in the perineum: a case report[J]. Front Med, 2012, 6(4): 440-443.
[10] Yu Liao, Yufei Xiang, Zhiguang Zhou. Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection[J]. Front Med, 2012, 6(3): 243-247.
[11] Zhonghua Sun. Multislice computed tomography angiography in the diagnosis of cardiovascular disease: 3D visualizations[J]. Front Med, 2011, 5(3): 254-270.
[12] Hong-Lian RUAN, Feng-Hua XU, Wen-Sheng LIU, Qi-Sheng FENG, Li-Zhen CHEN, Yi-Xin ZENG, Wei-Hua JIA, . Alcohol and tea consumption in relation to the risk of nasopharyngeal carcinoma in Guangdong, China[J]. Front. Med., 2010, 4(4): 448-456.
[13] Qin-Yan GAO, Hui-Min CHEN, Jing-Yuan FANG, Jian-Qiu SHENG, Ping ZHENG, Cheng-Gong YU, Bo JIANG, . The first year follow-up after colorectal adenoma polypectomy is important: A multiple-center study in symptomatic hospital-based individuals in China[J]. Front. Med., 2010, 4(4): 436-442.
[14] Hao WEN, Tuerganaili AJI, Ying-Mei SHAO, . Diagnosis and management against the complications of human cystic echinococcosis[J]. Front. Med., 2010, 4(4): 394-398.
[15] Qi-De LIN, Li-Hua QIU. Pathogenesis, diagnosis, and treatment of recurrent spontaneous abortion with immune type[J]. Front Med Chin, 2010, 4(3): 275-279.
Full text